HERE TIS:
HIGHLIGHTS
FY21 EBITDA expected to be at the top end of previous guidance of $45m - $47m
Strong FY21 operating cashflow (FY21 Net Cash of $12.2M from FY20 Net Debt of $8.4m)
Strong margin performance with increased overall margins in second half
Minimal impact of labour and COVID-19 challenges in FY21 due to the specialist nature of our business, diversity of service offering, diversity of sectors and geographic spread
Record Work in Hand of $1b (up 41% from FY20)
Well-funded for growth - available funds of $88.2m plus undrawn equipment facility of $27.7m
Long term Strategy on track and well positioned for long term sustainable growth
FY22 EBITDA expected to be ~15% higher than FY21 EBITDA result
STRATEGIC HORIZONS
Building the most sought-after specialist asset services, mining services and construction business
Step change growth in recurring Asset Services
Innovation and selective growth in Mining Services
Targeted growth in specialist Civil Infrastructure Construction
Specialist services and products in Building Construction with key repeat clients
Two thirds annuity / recurring and one third project-based earnings
Zero Harm / ESG industry leader and recognised employer of choice
Key partner of choice in our specialised core markets with core clients
Consistent, above market shareholder returns (EPS and TSR)
Selective strategic acquisitions to complement capability / footprint
Two thirds annuity / recurring and one third project-based earnings.
Very nice. GLAH Mal....
- Forums
- ASX - By Stock
- Ann: FY21 Guidance Update & FY22 Outlook Announcement
HERE TIS:HIGHLIGHTS FY21 EBITDA expected to be at the top end...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SRG (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.19 |
Change
0.030(2.60%) |
Mkt cap ! $715.6M |
Open | High | Low | Value | Volume |
$1.16 | $1.19 | $1.16 | $2.294M | 1.953M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 16740 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.19 | 38390 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 16740 | 1.175 |
4 | 25696 | 1.170 |
5 | 63482 | 1.160 |
1 | 8647 | 1.155 |
2 | 5030 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.190 | 31740 | 3 |
1.195 | 18268 | 2 |
1.200 | 40028 | 6 |
1.205 | 20000 | 1 |
1.220 | 778 | 1 |
Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
Featured News
SRG (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, MD & CEO
James Graham
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online